Science Stock Performance

SSAA
 Stock
  

USD 9.90  0.03  0.30%   

Science Strategic has a performance score of 7 on a scale of 0 to 100. The entity has a beta of 0.0121, which indicates not very significant fluctuations relative to the market. Let's try to break down what Science's beta means in this case. As returns on the market increase, Science Strategic returns are expected to increase less than the market. However, during the bear market, the loss on holding Science Strategic will be expected to be smaller as well. Although it is important to respect Science Strategic current price movements, it is better to be realistic regarding the information on the equity's historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting Science Strategic technical indicators, you can presently evaluate if the expected return of 0.0149% will be sustainable into the future. Science Strategic right now has a risk of 0.16%. Please validate Science Strategic downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness to decide if Science Strategic will be following its existing price patterns.
  
Science Performance
7 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Science Strategic Acquisition are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Science Strategic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more

Science Price Channel

Quick Ratio0.18
Fifty Two Week Low9.61
Fifty Two Week High9.90

Science Strategic Relative Risk vs. Return Landscape

If you would invest  978.00  in Science Strategic Acquisition on May 13, 2022 and sell it today you would earn a total of  9.00  from holding Science Strategic Acquisition or generate 0.92% return on investment over 90 days. Science Strategic Acquisition is currently generating 0.0149% in daily expected returns and assumes 0.1613% risk (volatility on return distribution) over the 90 days horizon. In different words, 1% of stocks are less volatile than Science, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Science Strategic is expected to generate 5.31 times less return on investment than the market. But when comparing it to its historical volatility, the company is 7.86 times less risky than the market. It trades about 0.09 of its potential returns per unit of risk. The DOW is currently generating roughly 0.06 of returns per unit of risk over similar time horizon.

Science Strategic Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Science Strategic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Science Strategic Acquisition, and traders can use it to determine the average amount a Science Strategic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0924

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsSSAA
Estimated Market Risk
 0.16
  actual daily
 
 1 %
of total potential
 
11
Expected Return
 0.01
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 0.09
  actual daily
 
 7 %
of total potential
 
77
Based on monthly moving average Science Strategic is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Science Strategic by adding it to a well-diversified portfolio.

About Science Strategic Performance

To evaluate Science Strategic Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Science Strategic generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Science Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Science Strategic stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Science's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California. Science Strategic is traded on NASDAQ Exchange in the United States.

Things to note about Science Strategic

Checking the ongoing alerts about Science Strategic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Science Strategic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Science Strategic Alerts

Equity Alerts and Improvement Suggestions

Science Strategic has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.34, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Science Strategic until it has trouble settling it off, either with new capital or with free cash flow. So, Science Strategic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Science Strategic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Science to invest in growth at high rates of return. When we think about Science Strategic's use of debt, we should always consider it together with cash and equity.
Science Strategic Acquisition currently holds about 346.32 K in cash with (557.93 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Over 86.0% of the company shares are owned by institutional investors
Latest headline from www.globenewswire.com: EdtechX Holdings Acquisition Corp. II and zSpace to Present at the Oppenheimer 25th Annual Technology, Internet Communications Conference - GlobeNewswire
Additionally, take a look at World Market Map. Note that the Science Strategic information on this page should be used as a complementary analysis to other Science Strategic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Science Stock analysis

When running Science Strategic price analysis, check to measure Science Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Strategic is operating at the current time. Most of Science Strategic's value examination focuses on studying past and present price action to predict the probability of Science Strategic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Science Strategic's price. Additionally, you may evaluate how the addition of Science Strategic to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Science Strategic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Strategic. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Strategic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.23
Market Capitalization
383.1 M
Return On Assets
-0.0118
The market value of Science Strategic is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Strategic's value that differs from its market value or its book value, called intrinsic value, which is Science Strategic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Strategic's market value can be influenced by many factors that don't directly affect Science Strategic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Strategic's value and its price as these two are different measures arrived at by different means. Investors typically determine Science Strategic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Strategic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.